Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia

计划入组 150 人 · 首次发布于 2006 年 2 月 20 日

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

计划入组 54 人 · 首次发布于 2024 年 1 月 18 日

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

计划入组 46 人 · 首次发布于 2024 年 10 月 9 日

FM-VP4

SP4

MP4

VPI Pharmaceuticals Inc

Canada

Porcine Rotavirus Vaccines Face a Cross-Protection Gap as Reassortant Strains Emerge

ONO-4578 EP4 Antagonist Combination Shows Significant PFS Improvement in Advanced Gastric Cancer

Nxera Pharma Advances Novel EP4 Antagonist HTL0039732 to Phase 2a Trial for Advanced Solid Tumors